To hear about similar clinical trials, please enter your email below
Trial Title:
Music Therapy for Cancer Patients(Meraki_PC)
NCT ID:
NCT06345924
Condition:
Cancer
Palliative Care
Conditions: Keywords:
cancer
psychological intervention
palliative care
music therapy-based treatment
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
MERAKI_PC
Description:
The three music therapy sessions focus on helping the patient to adjust to their
situation. The aim is to provide emotional support and encourage communication between
family members through music. In addition, the therapy will help the patient to
appreciate their remaining abilities and encourage their involvement in the
rehabilitation process. The second session focuses on living in the present through
re-identification. The session aims to improve the symptoms associated with the illness
by focusing on the present situation and encouraging expression.
The main aim of the final session, 'The Journey of Life - Leaving a Mark', is to
recapitulate and provide support.
Songs are used during the session, taking into account musical preferences.
Arm group label:
Experimental group
Summary:
The overall aim of the study is to analyse the impact of a music therapy-based treatment
on the emotional well-being and quality of life of cancer patients in palliative care
(PC). To this end, the effectiveness and efficiency of a music therapy-based treatment to
improve adaptation to illness and psychological well-being in this population will be
validated and implemented.
Specifically, the implementation of an individualised treatment programme for palliative
care patients will be carried out.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- The patient is receiving palliative care for an oncological diagnosis and was
admitted to the hospital a week ago. They do not have moderate to severe cognitive
impairment. This treatment is for oncological patients in an advanced stage who are
receiving palliative anti-tumour treatment such as chemotherapy and/or radiotherapy.
These patients require support treatment that cannot be provided at home due to
their complexity. The patient is in an advanced or terminal phase of the disease
according to WHO criteria.
- Be over 18 years of age.
- Have preserved cognitive ability (SPMSQ, Pfeiffer). More than 2 errors (3 in
illiterate persons) would suggest the presence of cognitive impairment.
- Have signed the informed consent form
- Have completed at least 2 of the 3 treatment sessions and have completed the
pre-test and post-test assessment.
Exclusion Criteria:
-Estimated survival time. Patients with a life expectancy of two weeks or less shall not
be operated on.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Hospital Dr. Moliner
Address:
City:
Serra
Country:
Spain
Status:
Recruiting
Contact:
Last name:
Miguel Fombuena, PhD
Email:
fombuena_mig@gva.es
Investigator:
Last name:
Selene Valero-Moreno, PhD
Email:
Sub-Investigator
Investigator:
Last name:
Isabel Bellver Vercher
Email:
Sub-Investigator
Investigator:
Last name:
Ana Alegre Soler
Email:
Sub-Investigator
Investigator:
Last name:
José Jorge Botella Trellis, Dr.
Email:
Sub-Investigator
Investigator:
Last name:
Cristina Rocío Espejo Fernández, Dra.
Email:
Sub-Investigator
Investigator:
Last name:
María Carmen Badía Picazo, Dra.
Email:
Sub-Investigator
Start date:
March 1, 2024
Completion date:
July 2025
Lead sponsor:
Agency:
University of Valencia
Agency class:
Other
Source:
University of Valencia
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06345924
